Key result
The 1-month prevalence of antihypertensive, dyslipidemic, or antidiabetic medication use among US youths increased 15.2%, from 3.3 per 1000 in November 2004 to 3.8 per 1000 in June 2007.
Cross-Sectional (n=6,000,000)
There was a significant increase in the prescription of antihypertensive and antidiabetic medications among US children and adolescents between 2004 and 2007, particularly in the 6- to 11-year-old age group.
No takes yet. Share an insight, caveat, or question.
Rising youth cardiometabolic medication use warrants surveillance; leaves open drivers and long-term implications.
Liberman et al. (2009) conducted a cross-sectional in Hypertension, diabetes mellitus, and dyslipidemia (n=6,000,000). Antihypertensive, antidiabetic, and dyslipidemic prescription medications was evaluated on Monthly prevalence of prescription drug use. The 1-month prevalence of antihypertensive, dyslipidemic, or antidiabetic medication use among US youths increased 15.2%, from 3.3 per 1000 in November 2004 to 3.8 per 1000 in June 2007.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: